The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

Image Source: Zacks Investment Research Lilly has seen unparalleled success with its GLP-1 drugs, Mounjaro and Zepbound. In ...

“It is not one-size-fits-all, and every medication can have risks and side effects,” Mao added in a university news release. ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

Eli Lilly(NYSE:LLY) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

1. Expand Healthy Options: Increase your assortment of low-calorie and high-protein products, such as protein bars and ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the ...